AstraZeneca Pharma India Limited announced the appointment of Mrs. Sandhya Tejaswini Amanna as Director – Legal, effective March 18, 2026. This appointment has been approved by the Board based on the recommendation of the Nomination and Remuneration Committee. Mrs. Amanna joins the company from Danone India, bringing over two decades of legal, compliance, and governance experience across the pharmaceutical and FMCG sectors.
Board Approval for Senior Management Change
AstraZeneca Pharma India Limited has formally disclosed the appointment of a new Senior Management Personnel following the approval from its Board of Directors. The Board greenlit the selection based on the recommendation provided by the Nomination and Remuneration Committee during its meeting.
Key Appointment Details
The newly appointed official is Mrs. Sandhya Tejaswini Amanna, who will assume the role of Director – Legal. The appointment is set to be effective starting March 18, 2026, and is designated as a Full – time employment position within the company’s senior management framework.
Profile of the New Director – Legal
Mrs. Sandhya Amanna transitions to AstraZeneca from Danone India, where she held the position of Head of Legal, Compliance and Secretarial. She is a seasoned legal professional boasting over two decades of cross-sector experience, spanning manufacturing, FMCG, and the pharmaceutical industry.
Her expertise centers on leadership responsibilities in legal advisory, governance, and compliance functions. As an in-house counsel, her significant experience covers end-to-end contract management, dispute resolution, and complex legal risk management. She has also led notable intellectual property litigation and compliance initiatives within the pharmaceutical sector.
Academically, Mrs. Amanna holds an LLB degree from the University of Mumbai and is an alumna of Government Law College, Mumbai.
Director Relationships
It is noted that there are No Applicable Disclosures regarding relationships between Mrs. Amanna and existing directors of the Company.
Source: BSE
